Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Document › Details

Themis Bioscience N.V.. (11/8/18). "Press Release: Themis Bioscience Postpones Its Listing on Euronext Amsterdam [Not for United States, Canada, Australia or Japan or any other jurisdiction where unlawful]". Vienna.

Region Region Amsterdam
  Country Netherlands
Organisations Organisation Themis Bioscience N.V.
  Group Merck (US) (MSD) (Group)
  Organisation 2 Euronext Amsterdam N.V.
  Group Euronext (Group)
Products Product Measles Vector (MV) technology platform
  Product 2 investment banking
Index term Index term Themis Bioscience–SEVERAL: investment, 201810– IPO €35m to €55.3m on Euronext Amsterdam POSTPONED 11/18
Persons Person Tauber, Erich (Themis Bioscience GmbH 201505 CEO)
  Person 2 May, Stephanie (Trophic Communications 201801 before MacDougall European Office)
     


   
Record changed: 2018-11-12

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

More documents for Merck (US) (MSD) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80




» top